Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|August 8, 2022

A Summary of Clinical Challenges and an Introduction to Focal Therapy

Author(s)Mark Emberton, BSc, MBBS, FRSC (Urol), MD, FMedSci

Insights on the drawbacks of older treatment approaches for clinically localized prostate cancer and how strategically implementing focal therapies may address remaining unmet needs and clinical challenges.

Episodes in this series

EP. 1 The Diagnostic Journey of Prostate Cancer: Common Tests and Procedures Used in the US and UK

EP. 1 The Diagnostic Journey of Prostate Cancer: Common Tests and Procedures Used in the US and UK

EP. 2 Prostate Cancer Staging, Incidence of Clinically Localized Disease, and Patient Risk Stratification

EP. 2 Prostate Cancer Staging, Incidence of Clinically Localized Disease, and Patient Risk Stratification

EP. 3 A Historical Perspective on Treatment Options for Localized Prostate Cancer

EP. 3 A Historical Perspective on Treatment Options for Localized Prostate Cancer

EP. 4 A Summary of Clinical Challenges and an Introduction to Focal Therapy

EP. 4 A Summary of Clinical Challenges and an Introduction to Focal Therapy

EP. 5 Available Focal Therapy Options for Localized Prostate Cancer

EP. 5 Available Focal Therapy Options for Localized Prostate Cancer

EP. 6 Safety and Efficacy Data Supporting the Use of Focal Therapy in Patients with Prostate Cancer

EP. 6 Safety and Efficacy Data Supporting the Use of Focal Therapy in Patients with Prostate Cancer

EP. 7 Global Perspective: The Adoption of Focal Therapy in the US and UK

EP. 7 Global Perspective: The Adoption of Focal Therapy in the US and UK

EP. 8 The Impact of Focal Therapy on Prostate Cancer Treatment Paradigms and Patient Outcomes

EP. 8 The Impact of Focal Therapy on Prostate Cancer Treatment Paradigms and Patient Outcomes

EP. 9 Prevention and Mitigation of Focal Therapy-Related Side Effects

EP. 9 Prevention and Mitigation of Focal Therapy-Related Side Effects

EP. 10 Follow-up Considerations for Patients Receiving Focal Therapy

EP. 10 Follow-up Considerations for Patients Receiving Focal Therapy

EP. 11 Exciting Prospects for the Future of Localized Prostate Cancer Treatment

EP. 11 Exciting Prospects for the Future of Localized Prostate Cancer Treatment

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues

ByHannah Clarke

February 4th 2026

Vanquish Water Vapor System used in first commercial prostate ablation

ByHannah Clarke

February 4th 2026

EU agency recommends expanded approval of niraparib/abiraterone dual tablet in mHSPC

ByHannah Clarke

February 3rd 2026

Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC

ByHannah Clarke

February 3rd 2026

FDA updates in urology: January 2026

ByHannah Clarke

February 2nd 2026

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

Trending on Urology Times

FDA approves sildenafil oral film for men with erectile dysfunction

The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD

Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC

Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD

URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues